We have observed
16 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
POWDERY MIXTURE FOR PRODUCING TABLETS CONTAINING LEVETIRACETAM
A NEW THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT
COMPRESSED SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS PARTICULATE VALSARTAN AS THE ACTIVE INGREDIENT
High dose imatinib tablets
Compositions of Imatinib
PROCESS FOR PRODUCING A SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE ACTIVE INGREDIENT RASAGILINE
PHARMACEUTICAL PEMETREXED SOLUTION
Composition containing Apomorphine and a Divalent Metal Cation
DRUG ADMINISTERING DEVICE AND ASSEMBLY METHOD THEREFORE
APPARATUS AND CASE FOR INFUSION EQUIPMENT
ORAL FEBUXOSTAT TABLET
COMPOSITION CONTAINING APOMORPHINE AND A DIVALENT METAL CATION
METHOD FOR PRODUCING AN APIXABAN GRANULATE
TREATMENT OF FRUCTOSE MALABSORPTION